Are we finally nearing a treatment for Alzheimer's? | Science
Back in November, researchers hailed the dawn of a new era of Alzheimer’s therapies. After decades of failure, a clinical trial finally confirmed that a drug, lecanemab, was able to slow cognitive decline in patients with early stages of the disease. Ian Sample speaks to Prof Nick Fox about what these results mean, and what it could mean for the future of Alzheimer’s disease treatments.
Source: theguardian.com